Answers are grounded in this paper and cite their sources.
Background Autoimmune encephalitis (AE) in children represents a group of immune‐mediated brain disorders with mild to severe neurological complications that are mostly recoverable with appropriate timely therapy. AE is complicated to diagnose and manage, particularly in Latin America, where access to diagnostic tests and treatments is limited. This study aimed to compare clinical outcomes in pediatric patients with AE who tested positive for autoantibodies versus those who tested negative. Methods We conducted a retrospective cohort, secondary analysis of the multicenter study REAL LABIC, including data from multiple countries in Latin America. We divided patients with AE into two groups based on their autoimmune antibody status: those with positive antibodies (Ab+) and those with negative antibodies (Ab−). We compared presentation, treatment responses, and clinical outcomes between the two groups. Results A total of 37 (59.7%) were Ab+, while 25 (40.3%) were Ab−. Neurological symptoms at admission were similar between groups, except for behavioral disturbances, which were more frequent in Ab+ patients (89% vs. 60%, p = 0.012) and required more aggressive treatment, including second‐line therapies, intensive care unit (ICU) admission, and mechanical ventilation. Conclusions Children with antibody‐positive AE in Latin America had a more severe disease course and required more intensive therapeutic interventions than antibody‐negative patients. These findings underscore the importance of timely diagnosis and equitable access to advanced diagnostic and therapeutic resources in the region.
No takes yet. Share an insight, caveat, or question.
Domínguez-Rojas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: